---
title: 'Comparison of two autologous hematopoietic stem cell mobilization strategies
  in patients with multiple myeloma: CE plus G-CSF versus G-CSF only: A single-center
  retrospective analysis'
date: '2024-04-11'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38600674/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240411180910&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'BACKGROUND: Despite recent advances in the treatment of multiple myeloma,
  high-dose chemotherapy followed by autologous hematopoietic stem cell transplantation
  (ASCT) remains an essential therapeutic keystone. As for the stem cell mobilization
  procedure, different regimens have been established, usually consisting of a cycle
  of chemotherapy followed by application of granulocyte-colony stimulating factor
  (G-CSF), although febrile neutropenia is a common complication. Following ...'
disable_comments: true
---
BACKGROUND: Despite recent advances in the treatment of multiple myeloma, high-dose chemotherapy followed by autologous hematopoietic stem cell transplantation (ASCT) remains an essential therapeutic keystone. As for the stem cell mobilization procedure, different regimens have been established, usually consisting of a cycle of chemotherapy followed by application of granulocyte-colony stimulating factor (G-CSF), although febrile neutropenia is a common complication. Following ...